Empagliflozin Improves Cardiovascular Outcomes for Those With CVD
Among patients with type 2 diabetes, empagliflozin showed greater benefits in patients with CVD vs without.
Among patients with type 2 diabetes, empagliflozin showed greater benefits in patients with CVD vs without.